| abstract |
The invention relates to the novel products of formula (I): in which R1 represents optionally substituted aryl or heteroaryl; R represents H or else forms, with R1, a 5- or 6-membered ring fused to an aryl or heteroaryl residue, optionally containing one or more O, S, N, NH and Nalk, which is optionally substituted; R2, R3 independently represent H, Hal or alkyl optionally substituted with one or more Hal; R4 represents H; R5 represents an H or alkyl optionally substituted with one or more halogen atoms; these products being in all the isomer forms and the salts, as medicaments, in particular as inhibitors of AKT (PKB) phosphorylation. |